QurisAI Bio-AI

Categories: Healthcare, Research, Data Analysis | Pricing: Enterprise | Official Website ↗

QurisAI uses a hybrid Bio-AI approach with 'Patients-on-a-Chip' to predict drug safety and efficacy in humans, reducing clinical trial failures.

QurisAI addresses the challenge of drug development by predicting drug safety and efficacy in humans, aiming to reduce the high failure rate of drugs in clinical trials. The platform utilizes a unique machine-learning approach where drugs are tested on miniaturized 'Patients-on-a-Chip'. The data generated from these tests is automatically tagged and then used to train machine-learning models. This method allows QurisAI to generate classification algorithms that predict which drug candidates will safely work in humans, thereby speeding up drug development and potentially reducing the need for animal testing. QurisAI is led by a team of experts in machine learning, big data, genomics, and medical device development, with operations in Boston and Tel-Aviv. The company has secured significant funding and has been featured in various publications for its innovative approach to biopharma.

Key Features

AI safety prediction platform for drugs
Machine-learning trained by Patients-on-a-Chip
Automated data tagging for model training
Prediction of drug efficacy in humans
Reduction of clinical trial failures

Pros

Addresses high drug failure rates in clinical trials
Utilizes a novel hybrid Bio-AI approach
Reduces reliance on traditional animal testing
Leverages miniaturized 'Patients-on-a-Chip' for data generation
Backed by a team of experts and significant funding

Cons

Specific pricing information is not publicly available
Requires complex biological and AI expertise
Adoption may face regulatory hurdles in drug approval processes
Technology is highly specialized, not for general use
No direct mention of API availability for integration

Use Cases

Predicting drug safety profiles early in development
Identifying promising drug candidates for clinical trials
Reducing costs associated with drug development failures
Accelerating the drug discovery process
Minimizing animal testing in preclinical stages

Best For

Pharmaceutical companies
Biotechnology firms
Drug discovery researchers
Clinical research organizations

Platforms: Web

Watch demo on YouTube ↗

View full QurisAI Bio-AI profile on Tools-Radar | Browse Healthcare tools | Alternatives to QurisAI Bio-AI

Tools-Radar is a free directory of 10,000+ AI tools — discover, compare, and choose the right AI software for your needs. Visit tools-radar.com